Trial | NCT00604032  Report issue

Title

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%
Clinical Evaluation of the Phototoxic Potential of Atralin (Tretinoin) Gel, 0.05%

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    tretinoin ...

  • Study Participants

    60
To assess the potential of tretnoin gel 0.05% to produce phototoxic reactions, measured as skin reactions 24 and 48 hours after UV radiation of drug on skin.
Study Started
Jan 31
2008
Primary Completion
Jan 31
2008
Study Completion
Feb 29
2008
Last Update
Mar 28
2008
Estimate

Drug Atralin (tretinoin) Gel, 0.05%

Assess potential of tretinoin gel, 0.05% to produce phototoxic reactions, measured 24 and 48 hours after UV radiation of drug on the skin.

1 Placebo Comparator

Criteria 

Inclusion Criteria:

Normal healthy volunteers
18 years of age or older

Exclusion Criteria:

Less than 18 years of age
No Results Posted